Hammerman M R
George M. O'Brien Kidney and Urological Disease Center, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Pediatr Nephrol. 2000 Jun;14(6):513-7. doi: 10.1007/s004670050805.
The number of kidney transplantations performed per year is limited due to availability of donor organs. One possible solution to the organ shortage is the use of renal xenografts. However, the transplantation of xenografts is complicated by hyperacute and acute rejection. It has been postulated that the host immune response might be attenuated following the transplantation of renal precursor cells or embryonic kidneys (metanephroi) instead of developed (adult) kidneys. Transplanted metanephroi become chimeric organs in that their blood supply originates, at least in part, from the host. It is possible to transplant a developing metanephros, without the use of immunosuppression, from one rat to another. Transplanted metanephroi grow, develop, become vascularized, and function in host rats. Transplantation of metanephroi may be a promising novel therapeutic approach for the treatment of chronic renal failure.
由于供体器官的可用性,每年进行的肾移植数量有限。器官短缺的一个可能解决方案是使用肾异种移植。然而,异种移植会因超急性和急性排斥反应而变得复杂。据推测,移植肾前体细胞或胚胎肾(后肾)而非发育成熟的(成年)肾脏后,宿主的免疫反应可能会减弱。移植的后肾会成为嵌合器官,因为它们的血液供应至少部分来自宿主。不使用免疫抑制就有可能将发育中的后肾从一只大鼠移植到另一只大鼠。移植的后肾在宿主大鼠中生长、发育、血管化并发挥功能。后肾移植可能是治疗慢性肾衰竭的一种有前景的新型治疗方法。